Bioequivalence studies for generic drugs assess whether a generic drug product is pharmaceutically equivalent and bioequivalent to the reference drug. These studies compare the pharmacokinetic parameters of the generic and reference drugs to ensure comparable absorption, distribution, metabolism, and excretion in the body. Bioequivalence is a crucial requirement for regulatory approval of generic drugs, demonstrating that they are therapeutically equivalent and interchangeable with the reference product.